The total return over the past 12 months is -34.88% vs. +16.94% for the S&P 500. So far it's up +139.15% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (34.88%) | (16.75%) | (18.73%) | (2.54%) | N/A | N/A |
| Total Return CAGR | (34.88%) | (16.75%) | (18.73%) | (2.54%) | N/A | N/A |
| Revenue CAGR | (79.07%) | (55.18%) | +22.30% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Arcturus Therapeutics Holdings Inc. (ARCT)
| Year | Start price | End price | ARCT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.13 | $14.66 | +139.15% | +14.51% | +124.64% |
| 2025 | $16.97 | $6.13 | (63.88%) | +17.72% | (81.60%) |
| 2024 | $31.53 | $16.97 | (46.18%) | +24.89% | (71.07%) |
| 2023 | $16.96 | $31.53 | +85.91% | +26.19% | +59.72% |
| 2022 | $37.01 | $16.96 | (54.17%) | (18.17%) | (36.00%) |
| 2021 | $43.38 | $37.01 | (14.68%) | +28.74% | (43.42%) |
| 2020 | $10.87 | $43.38 | +299.08% | +18.37% | +280.71% |
| 2019 | $4.53 | $10.87 | +139.96% | +31.22% | +108.74% |
| 2018 | $7.95 | $4.53 | (43.02%) | (4.56%) | (38.46%) |
| 2017 | $14.70 | $7.95 | (45.92%) | +21.70% | (67.62%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
